NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-020-2025-0-PC-01 USE OF COFILIN-1 DERIVED PEPTIDES TO TREAT INFLAMMATORY DISEASES PCT PCT PCT/US2026/016007 Pending
NICHD E-028-2020-0-US-03 TAMPERLESS TENSOR ELASTOGRAPHY IMAGING US CON 19/545,175 Pending
NIDDK E-162-2023-0-EP-01 5-HT2B SEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF EP National Stage 24843877.2 Pending
NCI E-098-2018-0-US-02 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR US CON 19/536,953 Pending
NCATS E-001-2023-1-HK-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF HK EP 62026119170.9 Pending
NCI E-056-2023-0-AU-01 IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES AU National Stage 2024296108 Pending
NCI E-169-2024-0-US-02 LNA GAPMERS INHIBIT GROWTH OF CCK-BR POSITIVE CANCER US National Stage 19/509,008 Pending
NCI E-183-2017-0-US-03 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS US DIV 19/531,048 Pending
NCI E-125-2023-0-EP-01 FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS EP National Stage 24749087.3 Pending
NIAID E-165-2023-0-EP-01 BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES EP National Stage 24754460.4 Pending
NEI E-070-2019-0-AU-09 INTERLEUKIN-27 PRODUCING B-CELL AND USES THEREOF AU DIV 2026200686 Pending
NCI E-173-2024-0-PC-01 TEM8 MONOCLONAL ANTIBODIES AND THEIR USE PCT PCT PCT/US2026/012882 Pending
NCI E-188-2023-0-EP-01 HUMANIZED 40H3 ANTIBODY EP National Stage 24748511.3 Pending
NCI E-103-2019-0-US-02 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE US CON 19/460,144 Pending
NIDCR E-107-2022-1-US-03 Treatment Methods Of Triphenyl Calcilytic Compounds US CON 19/455,678 Pending
NCI E-132-2023-0-EP-01 T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION EP National Stage 24738177.5 Pending
NIAID E-165-2023-0-CN-01 BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES CN National Stage 202480048498.0 Pending
NIAID E-165-2023-0-US-02 BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES US National Stage 19/503,944 Pending
NCI E-125-2023-0-US-02 FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS US National Stage 19/503,627 Pending
NCI E-125-2023-0-CA-01 FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS CA National Stage 3299104 Pending
NCI E-056-2023-0-US-02 IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE
FAMILY AND USE IN ANTI-CANCER THERAPIES 		US National Stage 19/502,979 Pending
NCI E-202-2023-0-US-02 KINASE INHIBITORS US National Stage 19/502,510 Pending
NCI E-056-2023-0-CA-01 IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES CA National Stage 3298848 Pending
NCI E-175-2016-0-AU-02 ANTI-KRAS-G12D T CELL RECEPTORS AU DIV 2026200276 Pending
NCI E-494-2013-0-AU-02 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS AU DIV 2026200282 Pending
NCI E-125-2023-0-AU-01 FULLY HUMAN MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AGAINST CD276 FOR THE TREATMENT OF SOLID TUMORS AU National Stage 2024295016 Pending
NCI E-158-2023-0-AU-01 POLYFLUORINATED THALIDOMIDE ANALOGS AND USES THEREOF AU National Stage 2024321683 Pending
NEI E-076-2023-0-EP-01 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS EP National Stage 24746096.7 Pending
NIDDK E-162-2023-0-US-02 5-HT2B SEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF US National Stage 19/501,756 Pending
NCI E-188-2023-0-AU-01 HUMANIZED 40H3 ANTIBODY AU National Stage 2024296940 Pending
NCI E-229-2014-0-CN-01 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation CN DIV 202610034476.X Pending
NEI E-076-2023-0-AU-01 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS AU National Stage 2024308721 Pending
NIAID E-153-2019-1-JP-16 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE JP DIV 2026-000223 Pending
NCI E-188-2023-0-JP-01 HUMANIZED 40H3 ANTIBODY JP National Stage 2026-500043 Pending
NINDS E-186-2023-1-EP-01 Uses of Iron Chelators for Treating Stuttering EP National Stage 24742436.9 Pending
NIAID E-165-2023-0-CA-01 BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES CA National Stage 3297535 Pending
NHLBI E-264-2023-0-PC-01 CAR WITH DUAL-VARIABLE DOMAIN AND ENHANCED TCR-SIGNALING TARGETING CT-RCC-1 PEPTIDE AND METHODS OF USE PCT PCT PCT/US2025/061839 Pending
NHLBI E-264-2023-1-PC-01 CAR WITH DUAL-VARIABLE-DOMAIN AND ENHANCED TCR-SIGNALING (CADET) AND METHODS OF USE PCT PCT PCT/US2025/061842 Pending
NEI E-076-2023-0-US-02 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS US National Stage 19/498,146 Pending
NCI E-188-2023-0-CA-01 HUMANIZED 40H3 ANTIBODY CA National Stage 3297257 Pending
NEI E-076-2023-0-CA-01 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS CA National Stage 3297165 Pending
NEI E-026-2025-0-PC-01 SYSTEMS AND METHODS FOR AN ARTIFICIAL INTELLIGENCE BASED WORKFLOW ASSISTANT FOR SINGLE CELL ANALYSIS PCT PCT PCT/US2025/061495 Pending
NIAID E-241-2014-0-JP-02 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/BPIV3 F PROTEIN AND USES THEREOF JP DIV 2025-283278 Pending
NCI E-042-2014-0-JP-02 Chimeric Antigen Receptors Targeting CD-19 JP DIV 2025-283967 Pending
NCI E-188-2023-0-US-02 HUMANIZED 40H3 ANTIBODY US National Stage 19/497,173 Pending
NINDS E-186-2023-1-US-01 Uses of Iron Chelators for Treating Stuttering US National Stage 19/496,195 Pending
NIAID E-086-2020-0-JP-19 SARS-CoV-2 VACCINE JP DIV 2025-272749 Pending
NEI E-293-2016-0-AU-02 TISSUE CLAMP AND IMPLANTATION METHOD AU DIV 2025283670 Pending
NICHD E-058-2021-0-JP-02 La Protein As A Novel Regulator Of Osteoclastogenesis JP DIV 2025-269776 Pending
NIAID E-135-2010-0-US-07 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 19/427,970 Pending